US Patent Issued to TRANSNEURAL THERAPEUTICS on Dec. 2 for "Fused heterocycles as 5-HT2A receptor agonists" (Massachusetts Inventors)

ALEXANDRIA, Va., Dec. 2 -- United States Patent no. 12,486,268, issued on Dec. 2, was assigned to TRANSNEURAL THERAPEUTICS INC. (Issaquah, Wash.).

"Fused heterocycles as 5-HT2A receptor agonists" was invented by Benito Munoz (Boston), Urjita H. Shah (Boston) and Paul Galatsis (Boston).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure provides compounds, e.g., compounds of Formula I, and their use in treating medical diseases or disorders, such as neurological disorders. Pharmaceutical compositions and methods of making various azaindole and benzisoxazole compounds are provided. The compounds are contemplated to be modulators of the 5-hydroxytryptamine 2A (5-HT2A) receptor."

The patent was filed o...